United Therapeutics (UTHR) Misses Q4 EPS by 21c

United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $3.51, $0.21 worse than the analyst estimate of $3.72. Revenue for the quarter came in at $415.2 million versus the consensus estimate of $427.62 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.

You May Also Be Interested In

• IMF chief says global economy weathered Iran war shock well
• Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
• The Marzetti Company (MZTI) Tops Q2 EPS by 6c